Literature DB >> 25624307

Explaining the variation between practices in the duration of new antidepressant treatment: a database cohort study in primary care.

Christopher Burton1, Isobel Cameron1, Niall Anderson2.   

Abstract

BACKGROUND: Practices vary in the duration of newly initiated antidepressant treatment, even after adjusting for patient characteristics. It was hypothesised that this may be because of differences between practices in demographic (practice deprivation and antidepressant prescribing rates), organisational (practice size and proportion of female GPs), and clinical factors (proportion of new episodes of depression coded). AIM: To examine the effect of practice characteristics on the duration of new selective serotonin reuptake inhibitor antidepressant treatment in primary care. DESIGN AND
SETTING: Database cohort study of 28 027 patients from 237 GP practices in Scotland.
METHOD: Prescription data were used to estimate duration of treatment for individual patients beyond three time points: 30, 90, and 180 days. Data at patient and practice level were analysed by multilevel logistic regression to quantify the variation between practices.
RESULTS: The mean rate of diagnostic coding for depression in patients beginning a course of treatment was 29% (range 0-80%). Practice-level deprivation and rate of new antidepressant prescribing were not associated with duration of treatment. The practice level factor most strongly associated with duration of treatment at practice level was the proportion of patients coded as having depression: odds ratio for continuing beyond 30 days was 1.54 (95% confidence interval [CI] = 1.22 to 1.94); beyond 90 days, 1.37 (95% CI = 1.09 to 1.71); and beyond 180 days 1.41 (95% CI = 1.10 to 1.82).
CONCLUSION: Encouraging coding and structured follow-up at the onset of treatment of depression is likely to reduce early discontinuation of antidepressant treatment and improve outcomes. © British Journal of General Practice 2015.

Entities:  

Keywords:  antidepressant treatment; clinical practice variation; depressive disorder; prescribing; primary health care

Mesh:

Substances:

Year:  2015        PMID: 25624307      PMCID: PMC4325457          DOI: 10.3399/bjgp15X683557

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  21 in total

1.  Factors influencing variation in prescribing of antidepressants by general practices in Scotland.

Authors:  Jill Morrison; Mary-Jane Anderson; Matt Sutton; Rosalia Munoz-Arroyo; Sara McDonald; Margaret Maxwell; Andrew Power; Michael Smith; Philip Wilson
Journal:  Br J Gen Pract       Date:  2009-02       Impact factor: 5.386

2.  Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis.

Authors:  Bruce Arroll; Steve Macgillivray; Simon Ogston; Ian Reid; Frank Sullivan; Brian Williams; Iain Crombie
Journal:  Ann Fam Med       Date:  2005 Sep-Oct       Impact factor: 5.166

3.  Influence of socio-economic deprivation on the prevalence and outcome of depression in primary care: the Hampshire Depression Project.

Authors:  K Ostler; C Thompson; A L Kinmonth; R C Peveler; L Stevens; A Stevens
Journal:  Br J Psychiatry       Date:  2001-01       Impact factor: 9.319

4.  Exploring potential explanations for the increase in antidepressant prescribing in Scotland using secondary analyses of routine data.

Authors:  Rosalia Munoz-Arroyo; Matt Sutton; Jill Morrison
Journal:  Br J Gen Pract       Date:  2006-06       Impact factor: 5.386

5.  Early discontinuation of antidepressants in general practice: association with patient and prescriber characteristics.

Authors:  Dorte Gilså Hansen; Werner Vach; Jens-Ulrik Rosholm; Jens Søndergaard; Lars F Gram; Jakob Kragstrup
Journal:  Fam Pract       Date:  2004-11-01       Impact factor: 2.267

Review 6.  Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review.

Authors:  John R Geddes; Stuart M Carney; Christina Davies; Toshiaki A Furukawa; David J Kupfer; Ellen Frank; Guy M Goodwin
Journal:  Lancet       Date:  2003-02-22       Impact factor: 79.321

7.  Antidepressant utilisation patterns and determinants of short-term and non-psychiatric use in the Finnish general adult population.

Authors:  Sinikka Sihvo; Erkki Isometsä; Olli Kiviruusu; Juha Hämäläinen; Jaana Suvisaari; Jonna Perälä; Sami Pirkola; Samuli Saarni; Jouko Lönnqvist
Journal:  J Affect Disord       Date:  2008-02-13       Impact factor: 4.839

Review 8.  "Medication career" or "moral career"? The two sides of managing antidepressants: a meta-ethnography of patients' experience of antidepressants.

Authors:  Alice Malpass; Alison Shaw; Debbie Sharp; Fiona Walter; Gene Feder; Matthew Ridd; David Kessler
Journal:  Soc Sci Med       Date:  2008-11-17       Impact factor: 4.634

Review 9.  Assessing depression severity using the UK Quality and Outcomes Framework depression indicators: a systematic review.

Authors:  Elizabeth J Shaw; Daniel Sutcliffe; Terence Lacey; Tim Stokes
Journal:  Br J Gen Pract       Date:  2013-05       Impact factor: 5.386

10.  Twelve month outcome of depression in general practice: does detection or disclosure make a difference?

Authors:  C Dowrick; I Buchan
Journal:  BMJ       Date:  1995-11-11
View more
  1 in total

1.  Can we trust studies using audit software? A case study of atrial fibrillation audit.

Authors:  Rebecca Rice; Lesley Roberts; David Fitzmaurice
Journal:  Br J Gen Pract       Date:  2015-11       Impact factor: 5.386

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.